Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells

Epithelial ovarian cancer (EOC) is the leading cause of gynaecological cancer-related death in Europe. Although most patients achieve an initial complete response with first-line treatment, recurrence occurs in more than 80% of cases. Thus, there is a clear unmet need for novel second-line treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Owens, Gemma L., Price, Marcus J., Cheadle, Eleanor J., Hawkins, Robert E., Gilham, David E., Edmondson, Richard J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182400/
https://www.ncbi.nlm.nih.gov/pubmed/30039427
http://dx.doi.org/10.1007/s00262-018-2211-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182400/
https://www.ncbi.nlm.nih.gov/pubmed/30039427
http://dx.doi.org/10.1007/s00262-018-2211-3

Ejemplares similares